Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Glibenclamide 1.25 mg and metformin hydrochloride 250 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
Product containing precisely glibenclamide 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely glibenclamide 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
Glibenclamide 5 mg and metformin hydrochloride 500 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Glibenclamide 5 mg and metformin hydrochloride 500 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
Product containing precisely desogestrel 100 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely desogestrel 100 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
Cyclobenzaprine hydrochloride 5 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
Ethinylestradiol 5 microgram and norethisterone acetate 1 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Ethinylestradiol 5 microgram and norethisterone acetate 1 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
konjugerede østrogener, 0,3 mg + medroxyprogesteronacetat 1,5 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
konjugerede østrogener, 0,3 mg + medroxyprogesteronacetat 1,5 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
konjugerede østrogener 0,45 mg + medroxyprogesteronacetat 1,5 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
konjugerede østrogener 0,45 mg + medroxyprogesteronacetat 1,5 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
konjugerede østrogener 0,625 mg + medroxyprogesteronacetat 2,5 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
konjugerede østrogener 0,625 mg + medroxyprogesteronacetat 2,5 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
konjugerede østrogener 0,625 mg + medroxyprogesteronacetat 5 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
konjugerede østrogener 0,625 mg + medroxyprogesteronacetat 5 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
Fenofibrate 54 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
fluoxetinhydrochlorid 20 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Glipizide 2.5 mg and metformin hydrochloride 250 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Glipizide 2.5 mg and metformin hydrochloride 250 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
Glipizide 2.5 mg and metformin hydrochloride 500 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Glipizide 2.5 mg and metformin hydrochloride 500 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
Glipizide 5 mg and metformin hydrochloride 500 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Glipizide 5 mg and metformin hydrochloride 500 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
Guanidine hydrochloride 125 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely cinacalcet (as cinacalcet hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Cinacalcet (as cinacalcet hydrochloride) 60 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely cinacalcet (as cinacalcet hydrochloride) 90 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Eszopiclone 1 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Eszopiclone 2 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Eszopiclone 3 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
fosinopril 10 mg + hydrochlorthiazid 12,5 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
fosinopril 10 mg + hydrochlorthiazid 12,5 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
fosinopril 20 mg + hydrochlorthiazid 12,5 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
fosinopril 20 mg + hydrochlorthiazid 12,5 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
Ethinylestradiol 35 microgram and norgestimate 180 microgram oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Ethinylestradiol 35 microgram and norgestimate 180 microgram oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
3 |
eprosartan 600 mg + hydrochlorthiazid 25 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
eprosartan 600 mg + hydrochlorthiazid 25 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
eprosartan 600 mg + hydrochlorthiazid 12,5 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
eprosartan 600 mg + hydrochlorthiazid 12,5 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
Difenidol hydrochloride 25 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely dexamethasone 250 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Dexamethasone 1.5 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Dexamethasone 6 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Fenofibrate 107 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Dehydroepiandrosterone 10 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Dehydroepiandrosterone 25 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Dehydroepiandrosterone 50 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Dehydroepiandrosterone 5 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Dimenhydrinate 50 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Doxylamine 25 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
emtricitabin 200 mg + tenofovir 136 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
emtricitabin 200 mg + tenofovir 136 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
Product containing precisely erlotinib (as erlotinib hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Erlotinib (as erlotinib hydrochloride) 25 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Estradiol acetate 450 microgram oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol acetate 900 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Estradiol acetate 1.8 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Ezetimibe 10 mg and simvastatin 10 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Ezetimibe 10 mg and simvastatin 10 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
Ezetimibe 10 mg and simvastatin 20 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Ezetimibe 10 mg and simvastatin 20 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
Ezetimibe 10 mg and simvastatin 40 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Ezetimibe 10 mg and simvastatin 40 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
Ezetimibe 10 mg and simvastatin 80 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Ezetimibe 10 mg and simvastatin 80 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
Fenofibrate 145 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Fenofibrate 48 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Glucosamine 750 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Drospirenone 2 mg and estradiol 1 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Drospirenone 2 mg and estradiol 1 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
Fenofibrate micronised 50 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Ethinylestradiol 2.5 microgram and norethisterone acetate 500 microgram oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Ethinylestradiol 2.5 microgram and norethisterone acetate 500 microgram oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
Entecavir 1 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Entecavir 500 microgram oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Dihydroergotamine mesilate 1 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Glucosamine 1 g oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Dexibuprofen 300 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Doxycycline 150 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Clozapine 50 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Dexibuprofen 400 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Doxycycline 75 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Doxycycline 50 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Drospirenone 500 microgram and estradiol 1 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Drospirenone 500 microgram and estradiol 1 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
doxazosin 8 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
Doxycycline 100 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |